In vitro antifungal activity of hydroxychavicol isolated from Piper betle L

Annals of Clinical Microbiology and Antimicrobials

Volumn 9, Issue , 2010, Pages

  Ali, Intzar ^a   Khan, Farrah G ^b   Suri, Krishan A ^a   Gupta, Bishan D ^a   Satti, Naresh K ^a   Dutt, Prabhu ^a   Afrin, Farhat ^c   Qazi, Ghulam N ^c   Khan, Inshad A ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

^b Acharya Shri Chander College of Medical Sciences   (India)

^c HAMDARD UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; HYDROXYCHAVICOL; PROPIDIUM IODIDE; UNCLASSIFIED DRUG; 2-HYDROXYCHAVICOL; 4 ALLYLCATECHOL; DRUG DERIVATIVE; EUGENOL;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; BIOFILM; CANDIDA ALBICANS; CANDIDA GLABRATA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DERMATOPHYTE; DRUG DETERMINATION; DRUG STRUCTURE; GROWTH INHIBITION; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PIPER BETLE; PLANT LEAF; CANDIDA; CHEMISTRY; DRUG EFFECT; FUNGUS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MUTATION; PHYSIOLOGY;

ANTIFUNGAL AGENTS; ASPERGILLUS; BIOFILMS; CANDIDA; EUGENOL; FUNGI; MICROBIAL SENSITIVITY TESTS; MUTATION; PIPER BETLE; PLANT LEAVES;

EID: 77950390432     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-9-7     Document Type: Article

References (30)

1. Fontenelle ROS, Morais SM, Brito EHS, Kerntopf MR, Brilhante RSN, Cordeiro RA, Tome AR, Queiroz MGR, Nascimento NRF, Sidrim JJC, Rocha MFG. Chemical composition, toxicological aspects and antifungal activity of essential oil from Lippia sidoides Cham. J Antimicrob Chemother 2007, 59:934-940. 10.1093/jac/dkm066, 17376793.
2. White TC, Marr KA, Bowden RA. Clinical, cellular and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998, 11:382-402. 106838, 9564569.
3. Muschietti L, Derita M, Sulsen V, de Dios Munoz J, Ferraro G, Zacchino S, Martino V. In vitro antifungal assay of traditional Argentine medicinal plants. J Ethnopharmacol 2005, 102:233-238. 10.1016/j.jep.2005.06.017, 16055292.
4. Nakamura CV, Ishida K, Faccin LC, Filho BPD, Cortez DAG, Rozental S, de Souza W, Ueda-Nakamura T. In vitro activity of essential oil from Ocimum gratissimum L. against four Candida species. Research in Microbiol 2004, 155:579-586.
5. Singh M, Shakya S, Soni VK, Dangi A, Kumar N, Bhattacharya SM. The n-hexane and chloroform fractions of Piper betle L., trigger different arms of immune responses in BALB/c mice and exhibit antifilarial activity against human lymphatic filarid Brugia malayi. Int Immunopharmacol 2009, 9:716-728. 10.1016/j.intimp.2009.02.012, 19281872.
6. Anonymous The Wealth of India. The Dictionary of Indian Raw Materials and Industrial Products. Raw Material, revised edition 1992, 5:84-94. Publication and Information directorate, CSIR, New Delhi, Anonymous.
7. Norton SA. Betel: consumption and consequences. J Am Acad Dermatol 1998, 38:81-88. 10.1016/S0190-9622(98)70543-2, 9448210.
8. Prabhu MS, Patel K, Saraawathi G, Srinivasan K. Effect of orally administered betel leaf (Piper betle leaf Linn.) on digestive enzymes of pancreas and intestinal mucosa and on bile production in rats. Indian J Expt Biol 1995, 33:752-756.
9. Bhattacharya S, Banergee D, Bauri AK, Chattopadhyay S, Bandyopadhyay SK. Healing properties of the Piper betle phenol, allylpyrocatechol against indomethacin-induced stomach ulceration and mechanism of action. World J Gastroenterol 2007, 21:3705-3713.
10. Chang MC, Uang BJ, Wu HL, Lee JJ, Hahn LJ, Jeng JH. Inducing the cell cycle arrest and apoptosis of oral KB carcinoma cells by hydroxychavicol: Roles of glutathione and reactive oxygen species. Br J Pharmacol 2002, 135:619-630. 10.1038/sj.bjp.0704492, 1573166, 11834609.
11. Chang MC, Uang BJ, Tsai CY, Wu HL, Lin BR, Lee CS, Chen YJ, Chang CH, Tsai YL, Kao CJ, Jeng JH. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization. Br J Pharmacol 2007, 152:73-82. 10.1038/sj.bjp.0707367, 1978281, 17641677.
12. Sharma S, Khan IA, Ali I, Ali F, Kumar M, Kumar A, Johri RK, Abdullah ST, Bani S, Pandey A, Suri KA, Gupta BD, Satti NK, Dutt P, Qazi GN. Evaluation of the antimicrobial, antioxidant and anti-inflammatory activities of hydroxychavicol for its potential use as an oral care agent. Antimicrob Agents Chemother 2009, 53:216-222. 10.1128/AAC.00045-08, 2612173, 18573934.
13. Ramji N, Ramji N, Iyer R, Chandrasekaran S. Phenolic antibacterials from Piper betle in the prevention of halitosis. J Ethnopharmacol 2002, 83:149-52. 10.1016/S0378-8741(02)00194-0, 12413722.
14. Green L, Petersen B, Steimel L, Haeber P, Current W. Rapid determination of antifungal activity by flow cytometry. J Clin Microbiol 1994, 32:1088-1091. 267192, 8027319.
15. Joung YH, Kim HR, Lee MK, Park AJ. Fluconazole susceptibility testing of Candida species by flow cytometry. J Infect 2007, 54:504-508. 10.1016/j.jinf.2006.09.016, 17084902.
16. Clinical and Laboratory Standards Institute (CLSI) Reference method for broth dilution antifungal susceptibility testing of yeasts, as the document is M27-A2., Wayne, PA. USA. Clinical and Laboratory Standards Institute (CLSI).
17. Clinical and Laboratory Standards Institute (CLSI) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, as the document is M38-A., Wayne, PA. USA. Clinical and Laboratory Standards Institute (CLSI).
18. Barros MES, Santos DA, Hamdan JS. In vitro methods for antifungal susceptibility testing of Trichophyton spp. Mycol Res 2006, 110:1355-1360. 10.1016/j.mycres.2006.08.006, 17070026.
19. Canton E, Peman J, Viudes A, Quindos G, Gobernado M, Espinel-Ingroff A. Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species. Diagn Microbiol Infect Dis 2003, 45:203-206. 10.1016/S0732-8893(02)00525-4, 12663162.
20. Ernst EJ, Roling EE, Petzold CR, Keele DJ, Klepser ME. In vitro activity of micafungin (FK-463) against Candida spp.: microdilution, time-Kill, and postantifungal-effect studies. Antimicrob Agents Chemother 2002, 46:3846-3853. 10.1128/AAC.46.12.3846-3853.2002, 132786, 12435687.
21. Craig WA, Gudmundsson S. Postantibiotic effect. Antibiotics in laboratory medicine 1996, 296-329. The Williams and Wilkins Co., Baltimore, MD. USA, Victor Lorian, 4.
22. Drugeon HB, Juvin ME, Bryskier A. Relative potential for selection of fluoroquinolone-resistant Streptococcus pneumoniae strains by levofloxacin: comparison with ciprofloxacin, sparfloxacin and ofloxacin. J Antimicrob Chemother 1999, 43(Suppl C):55-59. 10.1093/jac/43.suppl_3.55, 10404339.
23. Jin Y, Yip HK, Samaranayake YH, Yau JY, Samaranayake LP. Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J Clin Microbiol 2003, 41:2961-2967. 10.1128/JCM.41.7.2961-2967.2003, 165379, 12843027.
24. Ramage G, Walle KV, Wickes BL, Lopez-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 2001, 45:2475-2479. 10.1128/AAC.45.9.2475-2479.2001, 90680, 11502517.
25. Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL. Candida biofilms: an update. Euk Cell 2005, 4:633-638.
26. Pongpech P, Prasertsilpe V. The study of antimicrobial activity of Piper betle cream and gel against some fungi, yeast and bacteria. J GPO 1993, 19:8-22.
27. Trakranrungsie N, Chatchawanchonteera A, Khunkitti W. Ethnoveterinary study for antidermatophytic activity of Piper betle, Alpinia galanga and Allium ascalonicum extracts in vitro. Research in Vet Sci 2008, 84:80-84.
28. Cox SD, Mann CM, Markham JL, Gustafson JE, Warmington JR, Wyllie SG. Determining the antimicrobial actions of tea tree oil. Molecules 2001, 6:87-91.
29. Ramani R, Ramani A, Wong SJ. Rapid flow cytometric susceptibility testing of Candida albicans. J Clin Microbiol 1997, 35:2320-2324. 229962, 9276410.
30. Nalina T, Rahim ZHA. The crude aqueous extract of Piper betle L. and its antibacterial effect towards Streptococcus mutans. Am J Biotechnol Biochem 2007, 3:10-15.